Cargando…
GVS-12 attenuates non-alcoholic steatohepatitis by suppressing inflammatory responses via PPARγ/STAT3 signaling pathways
Non-alcoholic steatohepatitis (NASH), a type of fatty liver disease, is characterized by excessive inflammation and fat accumulation in the liver. Peroxisome proliferator-activated receptor γ (PPARγ) agonist rosiglitazone has great potential in protecting against the development of NASH. However, lo...
Autores principales: | Wang, Yuhui, Zhang, Xiyang, Yuan, Bo, Lu, Xi, Zheng, Dongxuan, Zhang, Kefeng, Zhong, Mingli, Xu, Xiaotian, Duan, Xiaoqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062151/ https://www.ncbi.nlm.nih.gov/pubmed/35520738 http://dx.doi.org/10.1039/c8ra10178g |
Ejemplares similares
-
VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin
por: Wang, Yuhui, et al.
Publicado: (2018) -
VSP-17 suppresses the migration and invasion of triple-negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway
por: Xu, Xiaotian, et al.
Publicado: (2021) -
Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model
por: Susutlertpanya, Warinda, et al.
Publicado: (2015) -
Is it time to stand united? Goat veterinary society (GVS)
por: Perkins, Nick, et al.
Publicado: (2020) -
PPARγ attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the miR-21-5p/SFRP5 pathway
por: Zhang, Xiying, et al.
Publicado: (2021)